Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
about
Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesFocused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor.Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of gliomaSensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyEnhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer.Nose-To-Brain Delivery of PLGA-Diazepam NanoparticlesDifferentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.Toward precision medicine in glioblastoma: the promise and the challenges.Improving drug delivery technology for treating neurodegenerative diseases.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Inhibition of glioma progression by a newly discovered CD38 inhibitor.Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route.Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery.Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model.An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.Comparative study between simple and optimized liposomal dispersion of quetiapine fumarate for diffusion through nasal route.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting.Recent Advances in the Therapeutic and Diagnostic Use of Liposomes and Carbon Nanomaterials in Ischemic StrokeEnhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience
P2860
Q28072442-6D36813D-A4FF-4F16-A795-6E49F5E488ABQ30380763-DAD48B30-A039-48BA-A780-FED9E019390EQ30413487-D98D1738-D653-4EB3-8890-5EECD47B7E87Q33683101-EF1AE1A6-6759-4694-B47E-A6C590D230F3Q33844966-CD025180-4228-4A29-82E4-380BFD342BBDQ36360517-41A30F63-E359-4A7F-BCBA-520B1E061EBBQ36370196-EC434C18-85B3-4F6C-9AFD-34E8E3E4ED88Q38236698-C73FE4F8-CAD3-4FE7-926A-250026A237DEQ38454659-C9DC6801-4C24-492A-B489-EE5E97493B86Q38769989-FF1CDD65-2CBF-4F82-A8AB-D2F43C96FE2AQ38862946-77B4A963-F12A-4DB5-A171-8D1E048BEDE1Q38972612-99CB63C9-B52F-4C40-96EA-FE1FB053E73FQ40315050-9EE898D4-6E13-40DE-9B7A-D6DA402571B4Q42315487-C9751CAD-0A0C-4B55-8368-48AF469A8ADCQ47984087-527BC389-EC0F-498A-B9D8-0B40A0333C2DQ48265111-C74D9EF6-11CE-44FC-B0E1-9AF189CAF161Q48497465-AAB9B307-5097-446A-AB1B-1191E92AAE4DQ52145252-B0B4485D-2615-490A-9254-A0686CAAC260Q52654049-7BE3AB1A-392D-4D5E-982E-0EAA68377E91Q53697270-F267FBE2-1856-4B2B-9145-527240331697Q54965858-89B8BFBA-9A17-4C17-88AB-61B4B91C5618Q57177063-BA7A5B1A-6D05-4CA7-BEE4-09DBA7FBAE61Q58777616-8BC47D80-8E08-4C4C-9E7F-9EAD7E70B31B
P2860
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@ast
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@en
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@nl
type
label
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@ast
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@en
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@nl
prefLabel
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@ast
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@en
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@nl
P2093
P2860
P50
P356
P1433
P1476
Formulations for Intranasal De ...... New Opportunity to Tackle GBM?
@en
P2093
Florence Lefranc
Karim Amighi
Matthias van Woensel
Stefaan W van Gool
Véronique Mathieu
P2860
P304
P356
10.3390/CANCERS5031020
P577
2013-08-14T00:00:00Z